EP3518962
SEBELIPASE ALFA FOR USE IN LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.9.2017EP published:
9.6.2021EP application number:
17791485.0
EPO information:
European Patent Register
Max expiry date:
27.9.2037
Title:
SEBELIPASE ALFA FOR USE IN LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE
Timeline
Today
28.9.2017EP application
9.6.2021EP Publication
Owner
Name:
Alexion Pharmaceuticals, Inc.Address:
121 Seaport Boulevard, Boston, MA 02210, US
Inventor
Name:
QUINN, AnthonyAddress:
Gloucester MA 01930, US
Name:
GOODMAN, ZacharyAddress:
Falls Church VA 22042, US
Name:
BURTON, BarbaraAddress:
Chicago IL 60611, US
Name:
RANKIN, AndrewAddress:
Boston MA 02110, US
Name:
FRIEDMAN, MarkAddress:
Newton MA 02461, US
Name:
SONI, PareshAddress:
Mystic CT 06355, US
Priority
Number:
201662402183 PDate:
30.9.2016Country:
US
Number:
201662420233 PDate:
10.11.2016Country:
US
Number:
201762456511 PDate:
8.2.2017Country:
US
Classification
Categories:
A61K 38/46, A61P 1/16, A61P 3/00